The dopamine DA-1 receptor agonist fenoldopam enhances amino-acid-induced hyperemia in dogs

Pharmacology. 1993 Jul;47(1):43-9. doi: 10.1159/000139077.

Abstract

The effect of the dopamine DA-1 receptor agonist fenoldopam on amino-acid-induced glomerular hyperemia and hyperfiltration was evaluated in conscious chronically instrumented dogs. Infusion of either amino acids (L-alanine, 4.1 mg/kg.min; L-proline, 3.2 mg/kg.min; L-serine, 2.9 mg/kg.min) or fenoldopam (0.05 micrograms/kg.min) alone resulted in significant (p < 0.05) increases in renal plasma flow of 85 +/- 41 and 53 +/- 24%, respectively. In dogs infused with both amino acids and fenoldopam, there was a dramatic (143 +/- 27%) increase in renal plasma flow (p < 0.01). This response was significantly greater than either treatment alone. The glomerular filtration rate did not change significantly when fenoldopam was infused; however, it increased to a similar degree when dogs were infused with either amino acids or a combination of fenoldopam and amino acids. The data suggest that fenoldopam either acts synergistically with amino acids to increase renal blood flow or perhaps magnifies the renal functional reserve.

MeSH terms

  • 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine / analogs & derivatives*
  • 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine / pharmacology
  • Alanine
  • Amino Acids
  • Animals
  • Dogs
  • Dopamine Agents / pharmacology*
  • Drug Synergism
  • Female
  • Fenoldopam
  • Glomerular Filtration Rate
  • Hyperemia / chemically induced
  • Hyperemia / physiopathology*
  • Proline
  • Renal Circulation / drug effects*
  • Serine
  • Sodium / urine

Substances

  • Amino Acids
  • Dopamine Agents
  • Serine
  • 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine
  • Proline
  • Sodium
  • Fenoldopam
  • Alanine